Genetic discovery to improve lung cancer treatment
Lung cancer is the deadliest form of cancer, accounting for an estimated 1.8 million deaths worldwide.
Jul 14, 2022
0
64
Lung cancer is the deadliest form of cancer, accounting for an estimated 1.8 million deaths worldwide.
Jul 14, 2022
0
64
A Melbourne study has found intravenously administering antibiotics to children at home is as effective and safe as hospital treatment and better for their quality of life when treating a bacterial skin infection.
Mar 8, 2019
0
6
(Medical Xpress) -- The future of drug design lies in developing therapies that can target specific cellular processes without causing adverse reactions in other areas of the nervous system. Scientists at the Universities ...
Nov 10, 2011
0
0
Cancer researchers at Children's Hospital of Philadelphia (CHOP) have harnessed tools used for the development of cancer immunotherapies and adapted them to identify regions of the SARS-CoV-2 virus to target with a vaccine, ...
Jun 9, 2020
0
126
While the drug tamoxifen reduces the risk of developing breast cancer and prevents recurrence, the side-effects cause many women to discontinue their treatment. A study involving researchers at Karolinska Institutet in Stockholm ...
Mar 18, 2021
0
144
People with a history of allergic-like reactions to iodinated contrast media, which is used in a variety of X-ray-based procedures, such as CT and angiography, are susceptible to similar reactions from commonly used MRI contrast ...
Feb 22, 2022
0
21
Researchers at Carlos III Universidad de Madrid have developed a system for detecting adverse effects of pharmaceutical drugs by tracking information generated by patients on specialized blogs or social networks such as Twitter ...
Mar 16, 2015
0
61
New medications created by pharmaceutical companies have helped millions of Americans alleviate pain and suffering from their medical conditions. However, the drug creation process often misses many side effects that kill ...
Oct 20, 2014
0
0
A multi-institutional group of researchers led by Harvard Medical School and the Novartis Institutes for BioMedical Research has created an open-source machine learning tool that identifies proteins associated with drug side ...
Jun 18, 2020
0
43
(HealthDay)—The combination of pembrolizumab and axitinib has been approved as a first-line treatment in advanced renal cell carcinoma (RCC), the U.S. Food and Drug Administration announced Friday.
Apr 23, 2019
0
2